Walleye Capital’s Lifestance Health LFST Stock Holding History

Walleye Capital’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,400	Closed	-$57.2K	–	4871
2025 Q3	$57.2K	Buy	10,400 +400	+4%	+$1.96K	﹤0.01%	3959
2025 Q2	$51.7K	Buy	+10,000	New	+$59.9K	﹤0.01%	4022

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SPIG

Silversmith Partners I GP Boston, Massachusetts $39.2M AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Walleye Capital's LFST Position: Q1 2026 in Review

Walleye Capital sold out of Lifestance Health (LFST) in Q1 2026, closing a stake of 315 shares — an estimated $2.22K sold.

Walleye Capital first reported a position in LFST in Q2 2021 and held it in 7 quarters. The position peaked at $838K in Q3 2025. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

Walleye Capital reported no remaining Lifestance Health position as of Q1 2026 after selling out during the quarter.
Walleye Capital sold 315 Lifestance Health shares in Q1 2026, an estimated $2.22K.
Walleye Capital first reported a position in Lifestance Health in Q2 2021 and held it in 7 quarters.
Walleye Capital's Lifestance Health position peaked at $838K in Q3 2025.
228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.